Upadacitinib demonstrates promising safety and efficacy in phase II/III SELECT-AXIS 1 study Nov. 25, 2019
AbbVie constructs anti-TNF-alpha antibody-steroid antibody-drug conjugate for rheumatoid arthritis Nov. 22, 2019
Rat homologue of FX-201 decreases incidence and severity of osteoarthritis-related lesions Nov. 21, 2019
RSS